143 related articles for article (PubMed ID: 9164475)
41. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis.
Andersson S; Rylander E; Larsson B; Strand A; Silfversvärd C; Wilander E
Eur J Cancer; 2001 Jan; 37(2):246-50. PubMed ID: 11166153
[TBL] [Abstract][Full Text] [Related]
42. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
43. Correlation of human papillomavirus 16 and 18 with cervical neoplasia in histological typing and clinical stage in Taiwan: an in-situ polymerase chain reaction approach.
Shyu JS; Chen CJ; Chiu CC; Huang SC; Harn HJ
J Surg Oncol; 2001 Oct; 78(2):101-9. PubMed ID: 11579387
[TBL] [Abstract][Full Text] [Related]
44. HPV genotyping in adenocarcinoma of the uterine cervix in Thailand.
Siriaunkgul S; Utaipat U; Suthipintawong C; Tungsinmunkong K; Triratanachat S; Khunamornpong S
Int J Gynaecol Obstet; 2013 Dec; 123(3):226-30. PubMed ID: 24095305
[TBL] [Abstract][Full Text] [Related]
45. Detection of human papillomavirus types in cervical adenocarcinoma by the polymerase chain reaction.
Lee MF; Chang MC; Wu CH
Int J Gynaecol Obstet; 1998 Dec; 63(3):265-70. PubMed ID: 9989896
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study.
An HJ; Kim KR; Kim IS; Kim DW; Park MH; Park IA; Suh KS; Seo EJ; Sung SH; Sohn JH; Yoon HK; Chang ED; Cho HI; Han JY; Hong SR; Ahn GH
Mod Pathol; 2005 Apr; 18(4):528-34. PubMed ID: 15502807
[TBL] [Abstract][Full Text] [Related]
47. Lethal endometrial recurrence after cone biopsy for microinvasive cervical adenocarcinoma.
Singh P; Scurry J; Proietto A
J Obstet Gynaecol Res; 2008 Jun; 34(3):413-7. PubMed ID: 18588617
[TBL] [Abstract][Full Text] [Related]
48. Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study.
Jenkins D; Molijn A; Kazem S; Pirog EC; Alemany L; de Sanjosé S; Dinjens W; Quint W
Int J Cancer; 2020 Nov; 147(9):2526-2536. PubMed ID: 32474915
[TBL] [Abstract][Full Text] [Related]
49. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus.
Jiko K; Tsuda H; Sato S; Hirohashi S
Int J Cancer; 1994 Dec; 59(5):601-6. PubMed ID: 7960232
[TBL] [Abstract][Full Text] [Related]
50. Comparison of human papillomavirus DNA levels in gynecological cancers: implication for cancer development.
Yang HJ; Liu VW; Tsang PC; Yip AM; Ng TY; Cheung AN; Ngan HY
Tumour Biol; 2003; 24(6):310-6. PubMed ID: 15004491
[TBL] [Abstract][Full Text] [Related]
51. Detection of human papillomavirus DNA in primary and metastatic lesions of carcinoma of the cervix in women from Okinawa, Japan.
Nagai Y; Maehama T; Asato T; Kanazawa K
Am J Clin Oncol; 2001 Apr; 24(2):160-6. PubMed ID: 11319292
[TBL] [Abstract][Full Text] [Related]
52. HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports.
Arfi A; Hequet D; Bataillon G; Tran-Perennou C; Farkhondeh F; Sastre-Garau X; Fourchotte V; Rouzier R; Laas E; Pouget N; Vincent-Salomon A; Jeannot E
BMC Cancer; 2019 Apr; 19(1):375. PubMed ID: 31014281
[TBL] [Abstract][Full Text] [Related]
53. Detection of human papilloma virus (HPV) infection in paraffin-embedded tissues of endometrial carcinoma.
Wong WS; Wong YF; Tam OS; Tam JS
Aust N Z J Obstet Gynaecol; 1993 May; 33(2):180-2. PubMed ID: 8216121
[TBL] [Abstract][Full Text] [Related]
54. No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group.
Wentzensen N; du Bois A; Kommoss S; Pfisterer J; von Knebel Doeberitz M; Schmidt D; Kommoss F
Int J Gynecol Pathol; 2008 Jan; 27(1):18-23. PubMed ID: 18156969
[TBL] [Abstract][Full Text] [Related]
55. Adenoid basal carcinoma of the uterine cervix: detection of integrated human papillomavirus in a rare tumor of putative "reserve cell" origin.
Grayson W; Taylor LF; Cooper K
Int J Gynecol Pathol; 1997 Oct; 16(4):307-12. PubMed ID: 9421068
[TBL] [Abstract][Full Text] [Related]
56. Cervical Adenocarcinoma: Diagnosis of Human Papillomavirus-Positive and Human Papillomavirus-Negative Tumors.
Pirog EC
Arch Pathol Lab Med; 2017 Dec; 141(12):1653-1667. PubMed ID: 28644686
[TBL] [Abstract][Full Text] [Related]
57. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women.
Huang S; Afonina I; Miller BA; Beckmann AM
Int J Cancer; 1997 Feb; 70(4):408-11. PubMed ID: 9033647
[TBL] [Abstract][Full Text] [Related]
58. Prevalence of HPV genotypes in cervical adenocarcinoma: a study in Greek women.
Chrysagi A; Kaparos G; Vrekoussis T; Yiannou P; Messini I; Patsouris E; Pavlakis K
J BUON; 2016; 21(3):666-72. PubMed ID: 27569088
[TBL] [Abstract][Full Text] [Related]
59. Comparison of 2 different PCR-based technologies for the detection of human papilloma virus from paraffin-embedded tissue: genómica clinical arrays versus SPF(10)-LiPA(25).
Pérez C; Klaustermeier JE; Alemany L; Tous S; de Sanjosé S; Velasco J
Diagn Mol Pathol; 2012 Mar; 21(1):45-52. PubMed ID: 22306675
[TBL] [Abstract][Full Text] [Related]
60. Adenocarcinoma of the uterine cervix: the presence of human papillomavirus and the method of detection.
Andersson S; Larson B; Hjerpe A; Silfverswärd C; Sällström J; Wilander E; Rylander E
Acta Obstet Gynecol Scand; 2003 Oct; 82(10):960-5. PubMed ID: 12956848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
